Efficient carcinoma cell killing by activated polymorphonuclear neutrophils targeted with an Ep-CAM×CD64 (HEA125×197) bispecific antibody
Christof Schweizer(German Cancer Research Center), Gerhard Moldenhauer(National Center for Tumor Diseases), Alexander Marmé, Gudrun Strauß(Universität Ulm), Matthias Lindner(Christian-Albrechts-Universität zu Kiel), Yashwant M. Deo
Cited by 16
Related Papers
Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19
|Immunity|2020|409
Therapeutic Potential of Amanitin-Conjugated Anti-Epithelial Cell Adhesion Molecule Monoclonal Antibody Against Pancreatic Carcinoma
|JNCI Journal of the National Cancer Institute|2012|192
CXCR3 Mediates Renal Th1 and Th17 Immune Response in Murine Lupus Nephritis
|The Journal of Immunology|2009|167
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors
|Cancer Biology & Therapy|2007|102